Do you want to read an article? Please log in or register.
Central nervous system metastases in metastatic breast cancer: Incidence, subtype-specific patterns, and outcomes from the Austrian AGMT_MBC registry
Breast Cancer
Related content
Breast Cancer
Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancer
Int J Cancer
Weller J, Katzendobler S, Thiele F, Riesberg A, Harter PN, Klauschen F, Wuerstlein R, Schoenecker S, Escudero MP, Forbrig R, Thon N, Ringel F, Weller M, Le Rhun E, Stoecklein VM
doi: 10.1002/ijc.70407
Breast Cancer
18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial
JAMA Oncol
van Geel JJL, Eisses B, Elias SG, Brouwers AH, Bensch F, Gerritse SL, Angus L, Glaudemans AWJM, Kuip EJM, Jager A, Oprea-Lager DE, Vugts DJ, Emmering J, Arens AIJ, Oyen WJG, van der Vegt B, Lub-de Hooge MN, Menke-van der Houven van Oord CW, de Vries EGE, Schröder CP, IMPACT-Metastatic Breast Cancer Consortium
doi: 10.1001/jamaoncol.2026.0767
Gastrointestinal Cancer
Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes
Eur J Cancer
Graus MUJE, van Diepen AE, Broekman T, van Eijck CWF, van Hooft JE, Homs MYV, Wumkes ML, Wilmink JW, de Hingh IHJT, Valkenburg-van Iersel LBJ, van der Geest LGM, Vos-Geelen J, Dutch Pancreatic Cancer Group (DPCG)
doi: 10.1016/j.ejca.2026.116263
Breast Cancer
Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancer
Lancet Oncol
Kaidar-Person O, Weltens CG, Fortpied C, Scheijmans LJEE, Kirkove CY, Budach V, Peignaux-Casasnovas K, Valli M, Peters M, van der Leij F, Rivera S, Weidner N, van den Bongard DHJG, Linsenmeier C, Abdah-Bortnyak R, Hosni S, Koiter E, Engelen AM, Baten A, Champezou L, Fourquet A, Bartelink HGMM, Struikmans H, Poortmans PMP, EORTC Radiation Oncology and Breast Cancer Groups
doi: 10.1016/S1470-2045(26)00233-0
Breast Cancer
Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registry
Int J Cancer
Marschner P, Ringwald K, Thill M, Zahn MO, Welt A, Nusch A, Kaltenecker G, Rodemer Y, Hagen V, Schock C, Kruggel L, Kaiser-Osterhues A, Klein D, Haug N, Stickeler E, Harbeck N, Wöckel A, Marschner N, Decker T, OPAL Registry Group
doi: 10.1002/ijc.70433
Breast Cancer
Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-mutant Metastatic Breast Cancer
Clin Cancer Res
Rugo HS, Kaklamani V, McArthur H, Wander SA, Gradishar W, Mahtani R, Pegram M, Lustberg M, Swallow E, Maitland J, Kloss S, Wasserman T, Tolaney SM
doi: 10.1158/1078-0432.CCR-25-3040
Breast Cancer
Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer: A Randomized Clinical Trial
JAMA Oncol
Karsten MM, Gebert P, Pross T, Hage AM, Dordevic AD, Stephan S, Kühn F, Doppelbauer L, Blohmer JU, Fischer F, Rose M, Pöhlmann A, Materne B, Petersen MA, Pauler L, Ferencz J, Wesselmann S, Breidenbach C, Grittner U, Kowalski C
doi: 10.1001/jamaoncol.2026.2661
RECOMMENDED
Head and Neck Cancer
Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non-small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Liu G, Abrahami D, Ramachandran P, Messina R, Rifi N, Yang H, Chai X, Li B, Ramaswamy K, Iyengar P, Pennell NA, Shaw AT
doi: 10.1016/j.lungcan.2025.108858
Further Publications
Incidence patterns and temporal trends of childhood cancer in Germany, 1980-2019: Forty years of childhood cancer registration in Germany
Int J Cancer
Erdmann F, Wellbrock M, Trübenbach C, Grabow D, Schrappe M, Kaatsch P, Spix C, Schüz J, Ronckers CM
doi: 10.1002/ijc.70167